Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-05 4:34 pm Purchase | 2021-10-22 | 13G | Xilio Therapeutics, Inc. XLO | RA Capital Management, L.P. | 1,532,767 5.700% | 1,532,767![]() (New Position) | Filing History |
| 2021-10-28 4:32 pm Purchase | 2009-02-28 | 13D | Forma Therapeutics Holdings, Inc. FMTX | RA Capital Management, L.P. | 9,029,184 19.050% | 17,533![]() (+0.19%) | Filing History |
| 2021-10-28 4:23 pm Purchase | 2009-02-28 | 13D | KALA BIO, Inc. KALA | RA Capital Management, L.P. | 438,461 16.850% | 3,477![]() (+0.80%) | Filing History |
| 2021-10-25 4:35 pm Purchase | 2021-10-13 | 13G | Otonomy, Inc. OTIC | RA Capital Management, L.P. | 3,092,294 5.500% | 3,092,294![]() (New Position) | Filing History |
| 2021-10-25 4:34 pm Purchase | 2021-10-13 | 13G | Pyxis Oncology, Inc. PYXS | RA Capital Management, L.P. | 1,914,934 5.800% | 1,914,934![]() (New Position) | Filing History |
| 2021-10-01 4:30 pm Purchase | 2021-09-23 | 13G | Synlogic, Inc. SYBX | RA Capital Management, L.P. | 444,444 9.900% | 444,444![]() (New Position) | Filing History |
| 2021-09-27 4:32 pm Purchase | 2021-09-17 | 13D | DICE Therapeutics, Inc. DICE | RA Capital Management, L.P. | 5,208,911 14.300% | 5,208,911![]() (New Position) | Filing History |
| 2021-09-27 4:30 pm Purchase | 2021-09-17 | 13D | Tyra Biosciences, Inc. TYRA | RA Capital Management, L.P. | 7,236,454 17.000% | 7,236,454![]() (New Position) | Filing History |
| 2021-09-14 4:30 pm Unchanged | 2009-02-28 | 13D | POINT Biopharma Global Inc. PNT | RA Capital Management, L.P. | 8,856,018 9.800% | 0 (Unchanged) | Filing History |
| 2021-09-13 4:30 pm Purchase | 2021-09-10 | 13D | Acumen Pharmaceuticals, Inc. ABOS | RA Capital Management, L.P. | 9,774,551 24.200% | 3,778![]() (+0.04%) | Filing History |
| 2021-08-23 4:30 pm Purchase | 2021-08-11 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | RA Capital Management, L.P. | 165,749 5.220% | 60,762![]() (+57.88%) | Filing History |
| 2021-08-19 4:30 pm Purchase | 2021-08-09 | 13D | Climb Bio, Inc. CLYM | RA Capital Management, L.P. | 13,151,959 50.000% | 13,151,959![]() (New Position) | Filing History |
| 2021-08-18 5:30 pm Purchase | 2009-02-28 | 13D | Wave Life Sciences Ltd. WVE | RA Capital Management, L.P. | 7,823,207 15.390% | 48,000![]() (+0.62%) | Filing History |
| 2021-08-16 4:32 pm Sale | 2021-08-16 | 13G | Adverum Biotechnologies, Inc. ADVM | RA Capital Management, L.P. | 0 0.000% | -950,238![]() (Position Closed) | Filing History |
| 2021-08-13 4:31 pm Purchase | 2021-08-03 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | RA Capital Management, L.P. | 1,606,859 5.600% | 1,606,859![]() (New Position) | Filing History |
| 2021-08-13 4:30 pm Purchase | 2021-08-03 | 13G | RxSight, Inc. RXST | RA Capital Management, L.P. | 3,052,796 11.100% | 3,052,796![]() (New Position) | Filing History |
| 2021-08-12 4:30 pm Purchase | 2021-08-02 | 13D | Icosavax, Inc. ICVX | RA Capital Management, L.P. | 5,779,347 14.700% | 5,779,347![]() (New Position) | Filing History |
| 2021-08-09 5:17 pm Purchase | 2021-07-30 | 13G | DA32 Life Science Tech Acquisition Corp. DALS | RA Capital Management, L.P. | 1,500,000 7.300% | 1,500,000![]() (New Position) | Filing History |
| 2021-08-09 4:32 pm Purchase | 2021-07-30 | 13G | Tenaya Therapeutics, Inc. TNYA | RA Capital Management, L.P. | 3,551,508 8.600% | 3,551,508![]() (New Position) | Filing History |
| 2021-08-06 4:30 pm Purchase | 2021-07-27 | 13D | Cytek Biosciences, Inc. CTKB | RA Capital Management, L.P. | 9,607,028 7.200% | 9,607,028![]() (New Position) | Filing History |

